Details for 2011838545
Up to date per 02.04.2026
Actions
Details for 2011838545
Granted/Registered
European Patent
04.09.2013 A
22.06.2016 B1
25.10.2010
US
406498 P
C07D 487/14 20060101AFI20140218BHEP
Owner
G1 Therapeutics, Inc.79 T.W. Alexander Drive 4401 Research Commons, Suite 105 Research Triangle Park, NC 27709US
Representative
Representative
Gibler & Poth Patentanwälte KGDorotheergasse 7/141010 WienAT
Inventor
TAVARES, Francis, X.c/o G-Zero Therapeutics, Inc. 450 West Drive; CB No.7295 Chapel Hill, NC 27599-7295US
STRUM, Jay C.c/o G-Zero Therapeutics, Inc. 450 West Drive; CB No.7295 Chapel Hill, NC 27599-7295US
Information about Fees